These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 14727004)

  • 21. The incidence of unpleasant dreams after sub-anaesthetic ketamine.
    Blagrove M; Morgan CJ; Curran HV; Bromley L; Brandner B
    Psychopharmacology (Berl); 2009 Mar; 203(1):109-20. PubMed ID: 18949459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism.
    Petrakis IL; Limoncelli D; Gueorguieva R; Jatlow P; Boutros NN; Trevisan L; Gelernter J; Krystal JH
    Am J Psychiatry; 2004 Oct; 161(10):1776-82. PubMed ID: 15465973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions.
    Krystal JH; Bennett A; Abi-Saab D; Belger A; Karper LP; D'Souza DC; Lipschitz D; Abi-Dargham A; Charney DS
    Biol Psychiatry; 2000 Jan; 47(2):137-43. PubMed ID: 10664830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ketamine for chronic pain: risks and benefits.
    Niesters M; Martini C; Dahan A
    Br J Clin Pharmacol; 2014 Feb; 77(2):357-67. PubMed ID: 23432384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nicotine fails to attenuate ketamine-induced cognitive deficits and negative and positive symptoms in humans: implications for schizophrenia.
    D'Souza DC; Ahn K; Bhakta S; Elander J; Singh N; Nadim H; Jatlow P; Suckow RF; Pittman B; Ranganathan M
    Biol Psychiatry; 2012 Nov; 72(9):785-94. PubMed ID: 22717030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis.
    Newcomer JW; Farber NB; Jevtovic-Todorovic V; Selke G; Melson AK; Hershey T; Craft S; Olney JW
    Neuropsychopharmacology; 1999 Feb; 20(2):106-18. PubMed ID: 9885791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia.
    Adler CM; Malhotra AK; Elman I; Goldberg T; Egan M; Pickar D; Breier A
    Am J Psychiatry; 1999 Oct; 156(10):1646-9. PubMed ID: 10518181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of chronic ketamine use on frontal and medial temporal cognition.
    Chan KW; Lee TM; Siu AM; Wong DP; Kam CM; Tsang SK; Chan CC
    Addict Behav; 2013 May; 38(5):2128-32. PubMed ID: 23435274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers.
    Gouzoulis-Mayfrank E; Heekeren K; Neukirch A; Stoll M; Stock C; Obradovic M; Kovar KA
    Pharmacopsychiatry; 2005 Nov; 38(6):301-11. PubMed ID: 16342002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacological modulation of the effects induced by ketamine at subanesthetic doses].
    Mechri A; Micallef J; Blin O; Saoud M; Daléry J; Gaha L
    Therapie; 2001; 56(5):617-22. PubMed ID: 11806303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of systemic N-methyl-D-aspartate receptor antagonist (ketamine) on primary and secondary hyperalgesia in humans.
    Ilkjaer S; Petersen KL; Brennum J; Wernberg M; Dahl JB
    Br J Anaesth; 1996 Jun; 76(6):829-34. PubMed ID: 8679358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NMDA antagonist effects on striatal dopamine release: positron emission tomography studies in humans.
    Kegeles LS; Martinez D; Kochan LD; Hwang DR; Huang Y; Mawlawi O; Suckow RF; Van Heertum RL; Laruelle M
    Synapse; 2002 Jan; 43(1):19-29. PubMed ID: 11746730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose-related ethanol-like effects of the NMDA antagonist, ketamine, in recently detoxified alcoholics.
    Krystal JH; Petrakis IL; Webb E; Cooney NL; Karper LP; Namanworth S; Stetson P; Trevisan LA; Charney DS
    Arch Gen Psychiatry; 1998 Apr; 55(4):354-60. PubMed ID: 9554431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective cognitive impairments associated with NMDA receptor blockade in humans.
    Rowland LM; Astur RS; Jung RE; Bustillo JR; Lauriello J; Yeo RA
    Neuropsychopharmacology; 2005 Mar; 30(3):633-9. PubMed ID: 15647751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans.
    Krystal JH; Karper LP; Bennett A; D'Souza DC; Abi-Dargham A; Morrissey K; Abi-Saab D; Bremner JD; Bowers MB; Suckow RF; Stetson P; Heninger GR; Charney DS
    Psychopharmacology (Berl); 1998 Feb; 135(3):213-29. PubMed ID: 9498724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments.
    Schmidt A; Bachmann R; Kometer M; Csomor PA; Stephan KE; Seifritz E; Vollenweider FX
    Neuropsychopharmacology; 2012 Mar; 37(4):865-75. PubMed ID: 22030715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-methyl-D-aspartate receptor in working memory impairments in schizophrenia: event-related potential study of late stage of working memory process.
    Ahn KH; Youn T; Cho SS; Ha TH; Ha KS; Kim MS; Kwon JS
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Sep; 27(6):993-9. PubMed ID: 14499316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonselective and NR2B-selective N-methyl-D-aspartic acid receptor antagonists produce antinociception and long-term relief of allodynia in acute and neuropathic pain.
    Swartjes M; Morariu A; Niesters M; Aarts L; Dahan A
    Anesthesiology; 2011 Jul; 115(1):165-74. PubMed ID: 21606828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers.
    Adler CM; Goldberg TE; Malhotra AK; Pickar D; Breier A
    Biol Psychiatry; 1998 Jun; 43(11):811-6. PubMed ID: 9611670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does ketamine-mediated N-methyl-D-aspartate receptor antagonism cause schizophrenia-like oculomotor abnormalities?
    Radant AD; Bowdle TA; Cowley DS; Kharasch ED; Roy-Byrne PP
    Neuropsychopharmacology; 1998 Nov; 19(5):434-44. PubMed ID: 9778665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.